reports
- Jonathan Moreland
Archrock Inc: 1 director
A director at Archrock Inc bought 10,000 shares at 24.158USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
- Jonathan Moreland
SNPS SYNOPSYS INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
NGL NGL ENERGY PARTNERS LP
MTDR MATADOR RESOURCES COMPANY
FRPT FRESHPET INC
BUSE FIRST BUSEY CORPORATION
ASA ASA
CELC CELCUITY
MBIN MERCHANTS BANCORP
AROC ARCHROCK INC.
CCEL CRYO-CELL INTERNATIONAL
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
ALXO ALX ONCOLOGY HOLDINGS
DLHC DALEIGH HOLDINGS CORP
AMR ALPHA METALLURGICAL RESOURCES INC
OPEN OPENDOOR TECHNOLOGIES INC.
CTO CONSOLIDATED-TOMOKA LAND CO
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
NEXT NEXT CAPITAL
RYAN RYAN SPECIALTY GROUP HLDGS INC
KMPH KEMPHARM INC
BUKS BUTLER NATIONAL CORP
OBLG OBLONG INC
VANI VIVANI MEDICAL INC
RH RESTORATION HARDWARE HOLDINGS INC
SMRT SMARTRENT INC
NBBK NB BANCORP INC.
NCDL NUVEEN CHURCHILL DIRECT LENDING CORP
BHRB BURKE HERBERT FINANCIAL SERVICES CORP
CAMP CAMP4 THERAPEUTICS CORPORATION
SI SHOULDER INNOVATIONS INC
MSTR MICROSTRATEGY INCORPORATED
- Jonathan Moreland
Kayne Anderson Energy Infrastructure Fund Prices Private Placement of ...
Kayne Anderson Energy Infrastructure Fund Prices Private Placement of $100 Million of Notes HOUSTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today that it reached an agreement with institutional investors relating to a private placement of $100 million of senior unsecured notes (“Notes”). The private placement is expected to close on or about October 15, 2025. Net proceeds will be used to refinance existing leverage and for general corporate purposes. The table below sets forth the key terms of the Note...
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance S...
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios as of August 31, 2025 HOUSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2025. As of August 31, 2025, the Company’s net assets were $2.3 billion, and its net asset value ...
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0...
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.08 per Share for September 2025 HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) announced today a monthly distribution of $0.08 per share for September 2025. This distribution is payable to common stockholders on September 30, 2025 (as outlined in the table below). The Company declares distributions on a monthly basis, with its next distribution expected to be declared in early October. Payment of future distributions is subject to the approval of the Com...
- Jonathan Moreland
GLP GLOBAL PARTNERS LP
ASA ASA
TZOO TRAVELZOO
MLP MAUI LAND & PINEAPPLE CO. INC.
MBIN MERCHANTS BANCORP
WU THE WESTERN UNION COMPANY
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
ASAN ASANA
ZIP ZIPRECRUITER
ENOV INC.
OBIO ENOVIS CORPORATION
SMRT ORCHESTRA BIOMED HOLDINGS INC
PROP SMARTRENT INC
BKKT PRAIRIE OPERATING CO.
MDRR BAKKT HOLDINGS INC.
MEDALIST DIVERSIFIED REIT INC.
Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Glo...
Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference AUSTIN, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders, such as Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced management’s participation in the H.C. Wainwright 27th Annual Global Investment Conference being held September 8 – 10, 2025 in New York City. Rick Barry, President and Chief Executive ...
- Jonathan Moreland
PRGO PERRIGO CO. PLC
POST POST HOLDINGS INC.
MGNX MACROGENICS INC.
MERC MERCER INTERNATIONAL INC.
LOB LIVE OAK BANCSHARES
HTH HILLTOP HOLDINGS INC.
HNRG HALLADOR ENERGY CO.
GLP GLOBAL PARTNERS LP
DIN DINE BRANDS GLOBAL INC.
CE CELANESE CORPORATION
QRHC QUEST RESOURCE HOLDING
HTLD HEARTLAND EXPRESS INC.
RSG REPUBLIC SERVICES INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
BSM BLACK STONE MINERALS LP
NTLA INTELLIA THERAPEUTICS INC.
CYRX CRYOPORT INC.
SD SANDRIDGE ENERGY INC.
ECIA ENCISION INC
UA UNDER ARMOUR
EOLS INC.
CCEL EVOLUS INC
ULBI CRYO-CELL INTERNATIONAL
AVTR ULTRALIFE
EPSN AVANTOR
ASAN INC.
OPCH EPSILON ENERGY LIMITED
MYO ASANA
ATAI OPTION CARE HEALTH INC
PFHC MYOMO
OPAL ATAI LIFE SCIENCES BV
CALC PROFRAC HLDG CORP
ET OPAL FUELS INC
PROP CALCIMEDICA INC.
FIP ENERGY TRANSFER LP
MDRR PRAIRIE OPERATING CO.
ECF FTAI INFRASTRUCTURE INC
LNW MEDALIST DIVERSIFIED REIT INC.
NUGN ELLSWORTH FUND LTD
EFOI LIGHT & WONDER INC.
SST LIVENTO GROUP
STRZ INC.
ENERGY FOCUS INC.
SYSTEM1 INC
STARZ ENTERTAINMENT CORP
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
PRGO PERRIGO CO. PLC
LOB LIVE OAK BANCSHARES
GLP GLOBAL PARTNERS LP
KYN KAYNE ANDERSON MLP INVESTMENT CO.
BSM BLACK STONE MINERALS LP
EPSN EPSILON ENERGY LIMITED
DLHC DALEIGH HOLDINGS CORP
GRNT GRANIT SKOPKE
ZIP ZIPRECRUITER
HUMA INC.
MDRR HUMACYTE INC
MEDALIST DIVERSIFIED REIT INC.
Kayne Anderson Energy Infrastructure Fund Inc: 2 directors
Two Directors at Kayne Anderson Energy Infrastructure Fund Inc bought 26,050 shares at 12.200USD. The significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
Cassava Reports Q2 2025 Financials Results and Provides Business Updat...
Cassava Reports Q2 2025 Financials Results and Provides Business Update Following positive preclinical data, simufilam development to advance with a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyRecent appointment of experienced neuroscience leaders to guide the clinical development strategy for simufilamAdvanced settlement negotiations ongoing to resolve certain securities litigation; $31.25 million estimated loss contingency recorded in Q2 for resolution$112.4 million in cash and cash equivalents at June 30, 2025 AUSTIN, Texas, Aug. 14, 2...
Archrock Announces Dual Listing on NYSE Texas
Archrock Announces Dual Listing on NYSE Texas HOUSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE:AROC) (“Archrock”) announced today the dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange headquartered in Dallas, Texas. “Our listing history with the New York Stock Exchange, through Archrock and its predecessor companies, began in 1997. We are pleased to join the NYSE Texas and support this pro-business initiative in the Lonestar State, which is home to our corporate headquarters and a majority of our compression operations,...
Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer
Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer Joseph Hulihan, MD, MSHP, brings substantial clinical development experience advancing novel therapies for TSC-related epilepsy and other neurological disordersClinical study for simufilam in TSC-related epilepsy expected to begin in H1 2026 AUSTIN, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders, today announced the appointme...
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
NSP INSPERITY INC.
NEO NEOGENOMICS INC.
MOH MOLINA HEALTHCARE INC.
MMLP MARTIN MIDSTREAM PARTNERS L.P.
CHD CHURCH & DWIGHT CO. INC.
ASUR ASURE SOFTWARE INC
SPT SPROUT SOCIAL
WSC INC.
DLHC WILLSCOT MOBILE MINI HOLDINGS CORP
ZIP DALEIGH HOLDINGS CORP
INTA ZIPRECRUITER
BRBR INC.
FINS INTAPP INC
MUSA BELLRING BRANDS INC
ANGEL OAK FINANCIAL STRATEGIES INCOME TERM TRUST
METALS USA HOLDINGS CORP.
Archrock Reports Second Quarter 2025 Results and Raises 2025 Financial...
Archrock Reports Second Quarter 2025 Results and Raises 2025 Financial Guidance HOUSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE: AROC) (“Archrock” or the “Company”) today reported results for the second quarter 2025. Second Quarter 2025 and Recent Highlights Revenue for the second quarter of 2025 was $383.2 million compared to $270.5 million in the second quarter of 2024.Net income for the second quarter of 2025 was $63.4 million and EPS was $0.36, compared to $34.4 million and $0.22, respectively, in the second quarter of 2024.Adjusted net income (a non-GAAP measure def...
Cassava Sciences Reports Positive Preclinical Study Evaluating Simufil...
Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy Study in a TSC mouse model further demonstrates simufilam’s anti-seizure activityStudy conducted in collaboration with TSC Alliance using a well-accepted Tsc1-knockout modelFirst clinical study for simufilam in TSC-related epilepsy expected to begin in H1 2026 AUSTIN, Texas, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on developing novel treatments for central nervous system (CNS) disorders...
- Jonathan Moreland
ANTM ANTHEM INC.
SSB SOUTH STATE CORPORATION
SNV SYNOVUS FINANCIAL CORP.
SIGI SELECTIVE INSURANCE GROUP INC.
SFNC SIMMONS FIRST NATIONAL CORPORATION CLASS A
RLI RLI CORP.
PSX PHILLIPS 66
PRGS PROGRESS SOFTWARE CORPORATION
PNFP PINNACLE FINANCIAL PARTNERS INC.
NVCR NOVOCURE LTD.
MTH MERITAGE HOMES CORPORATION
MSCI MSCI INC. CLASS A
MOFG MIDWESTONE FINANCIAL GROUP
FBIZ FIRST BUSINESS FINANCIAL SERVICES
CNC CENTENE CORPORATION
CHTR CHARTER COMMUNICATIONS INC. CLASS A
ALGN ALIGN TECHNOLOGY INC.
UPS UNITED PARCEL SERVICE INC. CLASS B
PETS PETMED EXPRESS INC.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
PBT PERMIAN BASIN ROYALTY TRUST
LIND LINDBLAD EXPEDITIONS HOLDINGS
KYN KAYNE ANDERSON MLP INVESTMENT CO.
PLBC PLUMAS BANCORP
CZWI CITIZENS COMMUNITY BANCORP
MBIN MERCHANTS BANCORP
PGC PEAPACK-GLADSTONE FINANCIAL CORP.
LOOP LOOP INDUSTRIES
CHMG CHEMUNG FINANCIAL CORP.
FVCB FVCBANKCORP
TLRY TILRAY
TROX TRONOX HOLDINGS PLC
AMTB AMERANT BANCORP (A)
PCB PACIFIC CITY FINANCIAL CORP
DMAC DIAMEDICA THERAPEUTICS INC.
CRDF CARDIFF ONCOLOGY INC
ABSI ABSCI CORP
NSPR INSPIREMD INC
BRCC BRC INC
JMSB JOHN MARSHALL BANCORP INC
PRME PRIME MEDICINE INC
MMC MARSH & MCLENNAN COMPANIES INC.
STRW STRAWBERRY FIELDS REIT INC.
AURX NUO THERAPEUTICS
DMA INC.
MRAI DESTRA MULTI ALTERNATIVE FUND
GF MARPAI
CVM INC.
THE NEW GERMANY FUND
INC.
CEL-SCI CORPORATION
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance S...
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios as of July 31, 2025 HOUSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of July 31, 2025. As of July 31, 2025, the Company’s net assets were $2.4 billion, and its net asset value per share...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.